Clinical Trial Update: Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 trial assessing postoperative radiation with cetuximab for locally advanced cutaneous squamous cell carcinoma of the head and neck completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma of the Head and Neck
• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: University of Cincinnati | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-05-10